Investigator's Initiated Phase II Study for Pancreatic Cancer Patients


NCT01659502

Interventional

Phase 2

Unknown status
The purpose of this study is to evaluate the efficacy, safety and tolerability of TL-118 alone or in combination with pancreatic cancer chemotherapy.
Dec 31,2013
All
18 Years
N/A
10

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.